Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
DEARGEN Inc.
About
  2. Companies
  3. DEARGEN Inc.
  4. Products
  5. DEARGEN - Model Dr. UG - Deep Learning ...

DEARGEN - Model Dr. UG - Deep Learning Technology

SHARE

Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.

Most popular related searches
small-molecule drug candidate
small molecule drug
small-molecule drug
genomic data
disease target
drug candidate
drug designation
genome analysis
precision medicine
genomic analysis
AI-Powered Target Discovery

The ‘DearTRANS’ (Genome Data Analysis) and ‘WX’(Biomarker Prediction) consisting of Dr.UG are DEARGEN`s artificial intelligence technologies that specialize in identifying disease-causing targets. Based on each AI technology, genomic data can be quickly compared and analyzed. Also, the disease target`s mode of action (MOA) and biomarkers can be predicted.

AI-Powered Drug Design

The DearDTI (Molecule Screening) and MolEQ (Lead Optimization) consisting of Dr.UG are DEARGEN`s artificial intelligence technologies that specialize in designing drug candidates for targets. Through the Molecule transformer technology, the affinity score between a target and a small molecule can be predicted. Based on this, small molecule drug candidates with higher efficacy can be designed by ADMET (absorption, distribution, metabolism, excretion, toxicity) optimization.